These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23052152)

  • 41. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double-blind controlled clinical trial.
    Abdollahi MH; Izadi A; Hajiesmaeili MR; Ghanizadeh A; Dastjerdi G; Hosseini HA; Ghiamat MM; Abbasi HR
    J ECT; 2012 Mar; 28(1):10-3. PubMed ID: 21983758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Side effects of electroconvulsive therapy.
    Datto CJ
    Depress Anxiety; 2000; 12(3):130-4. PubMed ID: 11126187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electroconvulsive therapy in China: clinical practice and research on efficacy.
    Tang YL; Jiang W; Ren YP; Ma X; Cotes RO; McDonald WM
    J ECT; 2012 Dec; 28(4):206-12. PubMed ID: 22801297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticonvulsants during electroconvulsive therapy: review and recommendations.
    Sienaert P; Peuskens J
    J ECT; 2007 Jun; 23(2):120-3. PubMed ID: 17548985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The immune system and electroconvulsive therapy for depression.
    Guloksuz S; Rutten BP; Arts B; van Os J; Kenis G
    J ECT; 2014 Jun; 30(2):132-7. PubMed ID: 24755720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Takotsubo cardiomyopathy after electroconvulsive therapy: a case report and review.
    Celano CM; Torri A; Seiner S
    J ECT; 2011 Sep; 27(3):221-3. PubMed ID: 21673587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hyperprolactinemia in subclinical hypothyroidism].
    Pietrobelli DJ; Artese R; Duhart JE; Katz D; Benencia H
    Medicina (B Aires); 2001; 61(3):275-8. PubMed ID: 11474873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum markers of brain-cell damage and C-reactive protein are unaffected by electroconvulsive therapy.
    Giltay EJ; Kho KH; Blansjaar BA
    World J Biol Psychiatry; 2008; 9(3):231-5. PubMed ID: 17853285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
    Watts BV; Groft A
    J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversible ischemic neurologic deficit after ECT.
    Miller AR; Isenberg KE
    J ECT; 1998 Mar; 14(1):42-8. PubMed ID: 9661093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The course of depressive symptoms in unipolar depressive disorder during electroconvulsive therapy: a latent class analysis.
    Cinar S; Oude Voshaar RC; Janzing JG; Birkenhäger TK; Buitelaar JK; van den Broek WW
    J Affect Disord; 2010 Jul; 124(1-2):141-7. PubMed ID: 19931917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting efficacy of electroconvulsive therapy in major depressive disorder.
    Tsuchiyama K; Nagayama H; Yamada K; Isogawa K; Katsuragi S; Kiyota A
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):546-50. PubMed ID: 16194256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modified electroconvulsive therapy for recurrent major depressive disorder in a meningioma patient: a case report of clinical experience.
    Nakatake M; Teraishi T; Ide M; Wakizono T; Ogawa T; Kuwahara T; Yoshino A; Nomura S
    Fukuoka Igaku Zasshi; 2010 Sep; 101(9):198-206. PubMed ID: 21222352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New-onset dissociative disorder after electroconvulsive therapy.
    Zaidner E; Sewell RA; Murray E; Schiller A; Price BH; Cunningham MG
    J ECT; 2010 Sep; 26(3):238-41. PubMed ID: 19935087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional neuroimaging changes subsequent to electroconvulsive therapy in unipolar depression: a review of the literature.
    Zhuo C; Yu C
    J ECT; 2014 Dec; 30(4):265-74. PubMed ID: 24625700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidences of menstrual cycle abnormalities in adolescence, and matches between the age at menarche and the development of menstrual cycle abnormalities.
    Art MJ; Doerfler D
    Wien Med Wochenschr; 2010 Aug; 160(15-16):406-13. PubMed ID: 20812052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A primer for the conceptualization of the mechanism of action of electroconvulsive therapy, 2: organizing the information.
    Andrade C
    J Clin Psychiatry; 2014 Jun; 75(6):e548-51. PubMed ID: 25004194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Takotsubo cardiomyopathy and electroconvulsive treatments: a case study and review.
    Serby MJ; Lantz M; Chabus BI; Bernay LJ
    Int J Psychiatry Med; 2010; 40(1):93-6. PubMed ID: 20565047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A primer for the conceptualization of the mechanism of action of electroconvulsive therapy, 1: defining the question.
    Andrade C
    J Clin Psychiatry; 2014 May; 75(5):e410-2. PubMed ID: 24922492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electroconvulsive Therapy in Patients With Cardiac Implantable Electronic Devices: A Case Report and Systematic Review of Published Cases.
    Purohith AN; Vaidyanathan S; Udupa ST; Munoli RN; Agarwal S; Prabhu MA; Praharaj SK
    J ECT; 2023 Mar; 39(1):46-52. PubMed ID: 35482902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.